Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom K Choi

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|May 20, 2020
Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia CellsFengjiao Chang, So Jung Kong, Lele Wang, et al.
Autophagy|July 22, 2016
Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagyKwang H Kim, Beom K Choi, Young H Kim, et al.
Journal of Leukocyte Biology|December 25, 2003
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cellsBeom K Choi, Jun S Bae, Eun M Choi, et al.
Cancer Letters|September 10, 2016
The repopulating cancer cells in melanoma are characterized by increased mitochondrial membrane potentialDon G Lee, Beom K Choi, Young H Kim, et al.
Current Eye Research|October 30, 2004
Herpesvirus infection of ICAM-1-deficient miceHyo W Jung, Cho-Rok Jung, Beom K Choi, et al.
Cellular Immunology|March 10, 2006
4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cellsYoung H Kim, Su K Seo, Beom K Choi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive TumorsHyeon-Seok Eom, Beom K Choi, Youngjoo Lee, et al.
Plos One|July 23, 2013
4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T CellsDo Y Lee, Beom K Choi, Don G Lee, et al.
Oncogene|November 7, 2021
Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1Dong Hoon Shin, Sun Ha Kim, Minyoung Choi, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2022
Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallengeHee Yeon Kim, Jae-Hyeog Choi, Md Masudul Haque, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|May 20, 2020
Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia CellsFengjiao Chang, So Jung Kong, Lele Wang, et al.
Autophagy|July 22, 2016
Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagyKwang H Kim, Beom K Choi, Young H Kim, et al.
Journal of Leukocyte Biology|December 25, 2003
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cellsBeom K Choi, Jun S Bae, Eun M Choi, et al.
Cancer Letters|September 10, 2016
The repopulating cancer cells in melanoma are characterized by increased mitochondrial membrane potentialDon G Lee, Beom K Choi, Young H Kim, et al.
Current Eye Research|October 30, 2004
Herpesvirus infection of ICAM-1-deficient miceHyo W Jung, Cho-Rok Jung, Beom K Choi, et al.
Cellular Immunology|March 10, 2006
4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cellsYoung H Kim, Su K Seo, Beom K Choi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 4, 2016
Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive TumorsHyeon-Seok Eom, Beom K Choi, Youngjoo Lee, et al.
Plos One|July 23, 2013
4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T CellsDo Y Lee, Beom K Choi, Don G Lee, et al.
Oncogene|November 7, 2021
Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1Dong Hoon Shin, Sun Ha Kim, Minyoung Choi, et al.
Cancer Immunology, Immunotherapy : CII|January 6, 2022
Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallengeHee Yeon Kim, Jae-Hyeog Choi, Md Masudul Haque, et al.
Pageof 7